Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2023 | Using ctDNA to identify mutations in colorectal cancer

John H. Strickler, MD, Duke Cancer Institute, Durham, NC, briefly discusses the advantages and limitations of using circulating tumor (ct)DNA to identify mutations, such as HER2 amplification, in colorectal cancer. This interview took place at the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.